Pages that link to "Q47824726"

The following pages link to Learning networks in health and Parkinson's disease: reproducibility and treatment effects. (Q47824726):

Displaying 35 items.

• Functional neuroimaging in Parkinson's disease (Q27013767) (← links)
• Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease. (Q30364799) (← links)
• Dopaminergic suppression of brain deactivation responses during sequence learning (Q30670363) (← links)
• Neuroimaging and therapeutics in movement disorders (Q30989947) (← links)
• Metabolic brain networks in neurodegenerative disorders: a functional imaging approach (Q33504970) (← links)
• Early Parkinson's disease: longitudinal changes in brain activity during sequence learning (Q33637837) (← links)
• Effects of dopamine medication on sequence learning with stochastic feedback in Parkinson’s disease (Q34081234) (← links)
• Abnormal regional brain function in Parkinson's disease: truth or fiction? (Q34160477) (← links)
• Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia. (Q34165820) (← links)
• Impaired sequence learning in dystonia mutation carriers: a genotypic effect (Q34180210) (← links)
• Diminished activation of motor working-memory networks in Parkinson's disease (Q34689266) (← links)
• Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study (Q34703465) (← links)
• Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease (Q35024422) (← links)
• Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease (Q35679727) (← links)
• Changes in network activity with the progression of Parkinson's disease (Q35679748) (← links)
• Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study (Q35679768) (← links)
• An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease (Q35684460) (← links)
• Metabolic brain networks associated with cognitive function in Parkinson's disease (Q35684482) (← links)
• Network modulation in the treatment of Parkinson's disease (Q35694166) (← links)
• Neuroimaging of Parkinson's disease and atypical parkinsonism (Q35817240) (← links)
• Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation (Q36020017) (← links)
• Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease (Q36021158) (← links)
• The assessment of neurological systems with functional imaging (Q36561279) (← links)
• Preclinical Huntington's disease: compensatory brain responses during learning (Q36846810) (← links)
• Dopamine overdose hypothesis: evidence and clinical implications (Q37384960) (← links)
• Levodopa medication improves incidental sequence learning in Parkinson's disease (Q37502519) (← links)
• Functional imaging of cognitive impairment in Parkinson's disease (Q37781045) (← links)
• Milestones in neuroimaging (Q37882576) (← links)
• A new multi-gram synthetic route to labeling precursors for the D(2/3) PET agent 18F-fallypride (Q38539219) (← links)
• The many facets of motor learning and their relevance for Parkinson's disease (Q39311516) (← links)
• Assessment of disease progression in parkinsonism (Q45125241) (← links)
• Task-related interaction between basal ganglia and cortical dopamine release. (Q46832195) (← links)
• Increased pre-SMA activation in early PD patients during simple self-initiated hand movements (Q48731785) (← links)
• Enhanced transformation of incidentally learned knowledge into explicit memory by dopaminergic modulation. (Q55365092) (← links)
• The Relationship Between the Striatal Dopaminergic Neuronal and Cognitive Function With Aging (Q90410764) (← links)